Patent landscape of nanotechnology – based nucleic acid delivery systems for breast cancer therapies
The findings highlight the transformative potential of nanotechnology for nucleic acid therapies in breast cancer. Despite manufacturing and regulatory challenges, the patent landscape demonstrates a dynamic and competitive field. Mapping technological developments provides valuable insights to guide strategic decisions in research and development and to identify underexplored areas with high innovation potential.
Authors
- Milca de Jesus Silva (ORCID: https://orcid.org/0000-0003-0554-1298)
- Cláudio Damasceno Pinto (ORCID: https://orcid.org/0000-0002-4963-5221)
- Helena Souza da Hora (ORCID: https://orcid.org/0000-0002-1953-6548)
- Katharine Valéria Saraiva Hodel (ORCID: https://orcid.org/0000-0001-7898-6672)
- Bruna Aparecida Souza Machado (ORCID: https://orcid.org/0000-0003-1655-0325)
- Thiago Barros Murari
- Larissa dos Santos Moraes Fonseca
Institutions
- Serviço Nacional de Aprendizagem Industrial (BR)
- Fundação Oswaldo Cruz (BR)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-01-14
- DOI
- https://doi.org/10.3389/fonc.2025.1702392
- Primary Topic
- RNA Interference and Gene Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00